InvestorsHub Logo
Followers 12
Posts 919
Boards Moderated 0
Alias Born 08/01/2006

Re: None

Saturday, 03/13/2010 5:01:53 PM

Saturday, March 13, 2010 5:01:53 PM

Post# of 854
Will be interesting to see how this trades going into approval. Given the previous track record with the FDA, I wouldn't be surprised to see it go mostly sideways.

I also wouldn't be surprised to see the PR come on Thursday or Friday given this is a re-submission.

Assuming it gets approved, I'm thinking $6-10 is probably a reasonable target out of the shoot. If a partnering deal follows immediately I think we could see $15-20 in short order. If not, price will probably pull back to the $5-6 range.

I think I read where the worldwide insomnia drug market is somewhere around $6.4B and the U.S. is 75% of the market. If Silenor could get 10% of the market with the right partner, a reasonable market cap would be around $500M (which is where I get the $20 target).

All MHO but I'm in for the ride, as I think this gets approved, and the biggest move doesn't come until the partnering deal is announced.

GLTA,

Murocman